Howe & Rusling Inc Vertex Pharmaceuticals Inc Transaction History

Howe & Rusling Inc

$1.09 Billion
Q2 2024

A detailed history of Howe & Rusling Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Howe & Rusling Inc holds 8,777 shares of VRTX stock, worth $4 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

8,777

Previous 8,137 7.87%

Holding current value

$4 Million

Previous $3.4 Million 20.94%

% of portfolio

0.38%

Previous 0.33%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $251,398 - $310,739	640 Added 7.87%	8,777 $4.11 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $41,176 - $45,054	101 Added 1.26%	8,137 $3.4 Million
Q4 2023 Feb 05, 2024	BUY	$343.0 - $410.68 $100,156 - $119,918	292 Added 3.77%	8,036 $3.27 Million
Q3 2023 Nov 08, 2023	SELL	$338.18 - $362.46 $90,294 - $96,776	-267 Reduced 3.33%	7,744 $2.69 Million
Q2 2023 Aug 14, 2023	SELL	$314.42 - $351.91 $106,588 - $119,297	-339 Reduced 4.06%	8,011 $2.82 Million
Q1 2023 May 15, 2023	SELL	$283.23 - $323.1 $61,744 - $70,435	-218 Reduced 2.54%	8,350 $2.63 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $24,861 - $27,968	-87 Reduced 1.01%	8,568 $2.47 Million
Q3 2022 Nov 14, 2022	BUY	$273.83 - $305.53 $83,791 - $93,492	306 Added 3.67%	8,655 $2.51 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $12,687 - $15,797	54 Added 0.65%	8,349 $2.35 Million
Q1 2022 May 10, 2022	SELL	$221.42 - $260.97 $662,931 - $781,344	-2,994 Reduced 26.52%	8,295 $2.17 Million
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $167,451 - $211,383	-946 Reduced 7.73%	11,289 $2.48 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $81,988 - $91,751	-452 Reduced 3.56%	12,235 $2.22 Million
Q2 2021 Aug 13, 2021	BUY	$187.49 - $221.1 $2.37 Million - $2.8 Million	12,653 Added 37214.71%	12,687 $2.56 Million
Q1 2021 May 13, 2021	SELL	$207.02 - $241.31 $1,242 - $1,447	-6 Reduced 15.0%	34 $7,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $2,277 - $3,036	11 Added 37.93%	40 $9,000
Q2 2020 Jul 15, 2020	SELL	$225.48 - $295.8 $2,029 - $2,662	-9 Reduced 23.68%	29 $8,000
Q2 2019 Aug 12, 2019	BUY	$164.61 - $190.37 $6,255 - $7,234	38 New	38 $7,000
Q4 2018 Feb 04, 2019	SELL	$151.91 - $192.21 $4,557 - $5,766	-30 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$167.73 - $192.74 $5,031 - $5,782	30 New	30 $6,000
Q2 2018 Jul 31, 2018	SELL	$145.72 - $169.96 $15,446 - $18,015	-106 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$151.6 - $177.13 $9,399 - $10,982	62 Added 140.91%	106 $17,000
Q3 2017 Oct 18, 2017	BUY	$148.13 - $162.24 $6,517 - $7,138	44	44 $7,000

Others Institutions Holding VRTX

# of Institutions

1,706

Shares Held

225M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $117B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Howe & Rusling Inc, based on Form 13F filings with the SEC.

News

Stay updated on Howe & Rusling Inc with notifications on news.

Account